0 0 1 0 1 B-lower_bound
to 2 4 2 4 O
< 5 6 5 6 O
2 7 8 7 8 B-upper_bound
years 9 14 9 14 I-upper_bound

0 0 1 15 16 B-lower_bound
to 2 4 17 19 O
less 5 9 20 24 O
than 10 14 25 29 O
18 15 17 30 32 B-upper_bound
years 18 23 33 38 I-upper_bound
of 24 26 39 41 O
age 27 30 42 45 B-age
at 31 33 46 48 O
the 34 37 49 52 O
time 38 42 53 57 O
of 43 45 58 60 O
informed 46 54 61 69 O
consent 55 62 70 77 O
/ 63 64 78 79 O
assent 65 71 80 86 O

Active 0 6 87 93 B-chronic_disease
infective 7 16 94 103 I-chronic_disease
endocarditis 17 29 104 116 I-chronic_disease

Active 0 6 117 123 B-chronic_disease
liver 7 12 124 129 I-chronic_disease
disease 13 20 130 137 I-chronic_disease

Anemia 0 6 138 144 B-chronic_disease
( 7 8 145 146 O
hemoglobin 8 18 146 156 B-clinical_variable
< 19 20 157 158 O
80g 21 24 159 162 B-upper_bound
/ 24 25 162 163 I-upper_bound
L 25 26 163 164 I-upper_bound
) 26 27 164 165 O

Clinical 0 8 166 174 O
indication 9 19 175 185 O
for 20 23 186 189 O
at 24 26 190 192 O
least 27 32 193 198 O
3 33 34 199 200 B-lower_bound
month 35 40 201 206 I-lower_bound
of 41 43 207 209 O
treatment 44 53 210 219 B-treatment
with 54 58 220 224 O
anticoagulants 59 73 225 239 B-treatment
for 74 77 240 243 O
the 78 81 244 247 O
VTE 82 85 248 251 O
episode 86 93 252 259 O
defined 94 101 260 267 O
under 102 107 268 273 O
the 108 111 274 277 O
above 112 117 278 283 O
inclusion 118 127 284 293 O
criterion 128 137 294 303 O

Documented 0 10 304 314 O
diagnosis 11 20 315 324 O
of 21 23 325 327 O
clinically 24 34 328 338 O
stable 35 41 339 345 O
VTE 42 45 346 349 B-chronic_disease
( 46 47 350 351 O
e.g. 47 51 351 355 O
DVT 52 55 356 359 B-chronic_disease
, 55 56 359 360 O
PE 57 59 361 363 B-chronic_disease
, 59 60 363 364 O
central 61 68 365 372 B-chronic_disease
line 69 73 373 377 I-chronic_disease
thrombosis 74 84 378 388 I-chronic_disease
, 84 85 388 389 O
sinus 86 91 390 395 B-chronic_disease
vein 92 96 396 400 I-chronic_disease
thrombosis 97 107 401 411 I-chronic_disease
) 107 108 411 412 O
per 109 112 413 416 O
investigator 113 125 417 429 O
judgment 126 134 430 438 O

Hepatic 0 7 439 446 B-chronic_disease
disease 8 15 447 454 I-chronic_disease

Male 0 4 455 459 B-gender
or 5 7 460 462 I-gender
female 8 14 463 469 I-gender
subjects 15 23 470 478 I-gender

Patients 0 8 479 487 O
who 9 12 488 491 O
are 13 16 492 495 O
allergic 17 25 496 504 O
/ 25 26 504 505 O
sensitive 26 35 505 514 O
to 36 38 515 517 O
any 39 42 518 521 O
component 43 52 522 531 O
of 53 55 532 534 O
the 56 59 535 538 O
study 60 65 539 544 O
medication 66 76 545 555 O
including 77 86 556 565 O
solvent 87 94 566 573 B-allergy_name

Patients 0 8 574 582 O
who 9 12 583 586 O
have 13 17 587 591 O
received 18 26 592 600 O
an 27 29 601 603 O
investigational 30 45 604 619 B-treatment
drug 46 50 620 624 I-treatment
in 51 53 625 627 O
the 54 57 628 631 O
past 58 62 632 636 B-upper_bound
30 63 65 637 639 I-upper_bound
days 66 70 640 644 I-upper_bound
prior 71 76 645 650 I-upper_bound
to 77 79 651 653 O
screening 80 89 654 663 O

Patients 0 8 664 672 O
who 9 12 673 676 O
have 13 17 677 681 O
taken 18 23 682 687 O
prohibited 24 34 688 698 O
or 35 37 699 701 O
restricted 38 48 702 712 O
medication 49 59 713 723 O
within 60 66 724 730 O
one 67 70 731 734 B-upper_bound
week 71 75 735 739 I-upper_bound
of 76 78 740 742 O
the 79 82 743 746 O
first 83 88 747 752 O
dose 89 93 753 757 O
of 94 96 758 760 O
study 97 102 761 766 O
medication 103 113 767 777 O
other 114 119 778 783 O
than 120 124 784 788 O
medication 125 135 789 799 O
for 136 139 800 803 O
prior 140 145 804 809 B-treatment
VTE 146 149 810 813 I-treatment
treatment 150 159 814 823 I-treatment
and 160 163 824 827 O
P 164 165 828 829 B-treatment
- 165 166 829 830 I-treatment
glycoprotein 166 178 830 842 I-treatment
inhibitors 179 189 843 853 I-treatment

Persistent 0 10 854 864 O
alanine 11 18 865 872 B-clinical_variable
aminotransferase 19 35 873 889 I-clinical_variable
( 36 37 890 891 I-clinical_variable
ALT 37 40 891 894 I-clinical_variable
) 40 41 894 895 I-clinical_variable

Renal 0 5 896 901 B-chronic_disease
dysfunction 6 17 902 913 I-chronic_disease

Subjects 0 8 914 922 O
with 9 13 923 927 O
a 14 15 928 929 O
heart 16 21 930 935 B-treatment
valve 22 27 936 941 I-treatment
prosthesis 28 38 942 952 I-treatment
requiring 39 48 953 962 O
anticoagulation 49 64 963 978 B-treatment

Transfusions 0 12 979 991 B-treatment
during 13 19 992 998 O
the 20 23 999 1002 O
screening 24 33 1003 1012 O
period 34 40 1013 1019 O
are 41 44 1020 1023 O
allowed 45 52 1024 1031 O
, 52 53 1031 1032 O
provided 54 62 1033 1041 O
that 63 67 1042 1046 O
a 68 69 1047 1048 O
satisfactory 70 82 1049 1061 O
hemoglobin 83 93 1062 1072 B-clinical_variable
or 94 96 1073 1075 O
platelet 97 105 1076 1084 B-clinical_variable
level 106 111 1085 1090 I-clinical_variable
is 112 114 1091 1093 O
attained 115 123 1094 1102 O
prior 124 129 1103 1108 O
to 130 132 1109 1111 O
visit 133 138 1112 1117 O
2 139 140 1118 1119 O

alkaline 0 8 1120 1128 B-clinical_variable
phosphatase 9 20 1129 1140 I-clinical_variable
( 21 22 1141 1142 I-clinical_variable
AP 22 24 1142 1144 I-clinical_variable
) 24 25 1144 1145 I-clinical_variable
> 26 27 1146 1147 O
3 28 29 1148 1149 B-lower_bound
Ã— 30 31 1150 1151 I-lower_bound
upper 32 37 1152 1157 I-lower_bound
limit 38 43 1158 1163 I-lower_bound
of 44 46 1164 1166 I-lower_bound
normal 47 53 1167 1173 I-lower_bound
( 54 55 1174 1175 I-lower_bound
ULN 55 58 1175 1178 I-lower_bound
) 58 59 1178 1179 I-lower_bound
within 60 66 1180 1186 O
3 67 68 1187 1188 B-upper_bound
months 69 75 1189 1195 I-upper_bound
of 76 78 1196 1198 O
screening 79 88 1199 1208 O

aspartate 0 9 1209 1218 B-clinical_variable
transaminase 10 22 1219 1231 I-clinical_variable
( 23 24 1232 1233 I-clinical_variable
AST 24 27 1233 1236 I-clinical_variable
) 27 28 1236 1237 I-clinical_variable

eGFR 0 4 1238 1242 B-clinical_variable
< 5 6 1243 1244 O
50 7 9 1245 1247 B-upper_bound
mL 10 12 1248 1250 I-upper_bound
/ 12 13 1250 1251 I-upper_bound
min/1.73m^2 13 24 1251 1262 I-upper_bound
using 25 30 1263 1268 O
the 31 34 1269 1272 O
Schwartz 35 43 1273 1281 O
formula 44 51 1282 1289 O

eGFR 0 4 1290 1294 B-clinical_variable
retesting 5 14 1295 1304 O
during 15 21 1305 1311 O
the 22 25 1312 1315 O
screening 26 35 1316 1325 O
period 36 42 1326 1332 O
is 43 45 1333 1335 O
allowed 46 53 1336 1343 O
( 54 55 1344 1345 O
once 55 59 1345 1349 O
) 59 60 1349 1350 O

including 0 9 1351 1360 O
known 10 15 1361 1366 O
active 16 22 1367 1373 O
hepatitis 23 32 1374 1383 B-chronic_disease
A 33 34 1384 1385 I-chronic_disease
, 34 35 1385 1386 I-chronic_disease
B 36 37 1387 1388 I-chronic_disease
or 38 40 1389 1391 I-chronic_disease
C 41 42 1392 1393 I-chronic_disease

initially 0 9 1394 1403 O
treated 10 17 1404 1411 O
( 18 19 1412 1413 O
minimum 19 26 1413 1420 O
of 27 29 1421 1423 O
5 30 31 1424 1425 B-lower_bound
to 32 34 1426 1428 O
7 35 36 1429 1430 B-upper_bound
days 37 41 1431 1435 I-upper_bound
, 41 42 1435 1436 O
but 43 46 1437 1440 O
not 47 50 1441 1444 O
longer 51 57 1445 1451 O
than 58 62 1452 1456 O
21 63 65 1457 1459 O
days 66 70 1460 1464 O
) 70 71 1464 1465 O
with 72 76 1466 1470 O
parenteral 77 87 1471 1481 B-treatment
anticoagulation 88 103 1482 1497 I-treatment
therapy 104 111 1498 1505 I-treatment

low 0 3 1506 1509 B-treatment
molecular 4 13 1510 1519 I-treatment
weight 14 20 1520 1526 I-treatment
heparin 21 28 1527 1534 I-treatment
( 29 30 1535 1536 I-treatment
LMWH 30 34 1536 1540 I-treatment
) 34 35 1540 1541 I-treatment

requirement 0 11 1542 1553 O
for 12 15 1554 1557 O
dialysis 16 24 1558 1566 B-treatment

thrombocytopenia 0 16 1567 1583 B-chronic_disease
( 17 18 1584 1585 O
platelet 18 26 1585 1593 B-clinical_variable
count 27 32 1594 1599 I-clinical_variable
< 33 34 1600 1601 O
80 35 37 1602 1604 B-upper_bound
x 38 39 1605 1606 I-upper_bound
109 40 43 1607 1610 I-upper_bound
/ 43 44 1610 1611 I-upper_bound
L 44 45 1611 1612 I-upper_bound
) 45 46 1612 1613 O
at 47 49 1614 1616 O
screening 50 59 1617 1626 O

unfractionated 0 14 1627 1641 B-treatment
heparin 15 22 1642 1649 I-treatment
( 23 24 1650 1651 I-treatment
UFH 24 27 1651 1654 I-treatment
) 27 28 1654 1655 I-treatment

unwarranted 0 11 1656 1667 B-treatment
radiation 12 21 1668 1677 I-treatment
exposure 22 30 1678 1686 I-treatment
as 31 33 1687 1689 O
a 34 35 1690 1691 O
result 36 42 1692 1698 O
of 43 45 1699 1701 O
a 46 47 1702 1703 O
repeat 48 54 1704 1710 O
CT 55 57 1711 1713 B-treatment
scan 58 62 1714 1718 I-treatment
at 63 65 1719 1721 O
day 66 69 1722 1725 O
84 70 72 1726 1728 O
for 73 76 1729 1732 O
a 77 78 1733 1734 O
patient 79 86 1735 1742 O
with 87 91 1743 1747 O
an 92 94 1748 1750 O
isolated 95 103 1751 1759 O
case 104 108 1760 1764 O
of 109 111 1765 1767 O
pulmonary 112 121 1768 1777 B-chronic_disease
embolism 122 130 1778 1786 I-chronic_disease
evaluated 131 140 1787 1796 O
at 141 143 1797 1799 O
baseline 144 152 1800 1808 O
solely 153 159 1809 1815 O
by 160 162 1816 1818 O
a 163 164 1819 1820 O
CT 165 167 1821 1823 O
scan 168 172 1824 1828 O

with 0 4 1829 1833 O
body 5 9 1834 1838 B-clinical_variable
weight 10 16 1839 1845 I-clinical_variable
lower 17 22 1846 1851 O
than 23 27 1852 1856 O
the 28 31 1857 1860 O
3rd 32 35 1861 1864 B-upper_bound
percentile 36 46 1865 1875 I-upper_bound

with 0 4 1876 1880 O
gestational 5 16 1881 1892 O
age 17 20 1893 1896 O
at 21 23 1897 1899 O
birth 24 29 1900 1905 O
< 30 31 1906 1907 O
37 32 34 1908 1910 B-upper_bound
weeks 35 40 1911 1916 I-upper_bound

